Clinical Trial Update: A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1 [Phase 1]

View source ↗

Summary

A Phase 1 dose-ranging study of an H7N9 virus-like particle influenza vaccine with adjuvant completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• H7N9 VLP influenza vaccine (influenza virus-like particle vaccine (H7N9))

Snippet

Sponsor: Novavax | Conditions: Avian Influenza | Phase 1 | Status: COMPLETED